학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 805건 | 목록 1~20
Academic Journal
Tjeertes J; Bayer AG, Basel, Switzerland.; Dostalek M; Bayer AG, Basel, Switzerland.; Glaus C; Bayer Research and Innovation Center, Bayer US, Cambridge, Massachusetts.; Gupta V; Bayer Research and Innovation Center, Bayer US, Cambridge, Massachusetts.; Li D; City of Hope Comprehensive Cancer Center, Duarte, California.; Nestler A; Bayer AG, Berlin, Germany.; Pelekanou V; Bayer Research and Innovation Center, Bayer US, Cambridge, Massachusetts.; Pinkert J; Bayer AG, Berlin, Germany.; Ratih I; Bayer PLC, Reading, Berkshire, United Kingdom.; Smith E; Bayer Research and Innovation Center, Bayer US, Cambridge, Massachusetts.; Subramanyam S; Bayer US, Whippany, New Jersey.; Vogel A; Toronto General Hospital and Princess Margaret Cancer Center, Toronto, Ontario, Canada.; Hannover Medical School, Hannover, Germany.; Walker K; Bayer PLC, Reading, Berkshire, United Kingdom.; Woods AW; Blue Faery, Birmingham, Alabama; and.; Zimmermann S; Bayer Research and Innovation Center, Bayer US, Cambridge, Massachusetts.; Junger H; Bayer AG, Berlin, Germany; henrik.junger@bayer.com.; University Hospital of Regensburg, Regensburg, Germany.
Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Book
Metabolism of Drugs and Other Xenobiotics. :147-164
Book
Metabolism of Drugs and Other Xenobiotics. :583-610
Academic Journal
Sloot, FreaHoeve, Hans L.J.de Kroon, Marlou L.A.Goedegebure, AndréCarlton, JillGriffiths, Helen J.Simonsz, Huibert J.Langmann, A.Lindner, S.Gaugl, H.ten Tusscher, M.Guérin, C.Hoppenbrouwers, K.van Lammeren, M.Boelaert, K.Godts, D.Paris, V.Bauwens, A.Stateva, D.Petrinovic-Doresic, J.Bjelos, M.Novak-Stroligo, M.Alpeza-Dunato, Z.Gavrielides Michaeloudes, M.Dostálek, M.Zobanova, A.Jerabkova, A.Hesgaard, H.Welinder, L. G.Sandfeld, L.Larsen, S.Levin, M.Klett, A.Somma, K.Ismagilova, S.Hyvärinen, L.Thouvenin, D.Coursager, K.Elflein, H.Pitz, S.Lenk-Schaefer, M.Van-Waveren, M.Ziakas, N. G.Polychroniadis Scouros, S.Knezy, K.Nemeth, J.Soproni, A.Facskó, A.Berkes, S.Gudmundsdottir, E.McCreery, K.Morad, Y.Ancri, O.Nucci, P.Serafino, M.Lembo, A.Bottin, D.Valeina, S.Misevice, A.Asoklis, R. S.Planata-Bogdan, B.Francalanza, M.Sjoerdsma, T.van Rijn, R.Osnes-Ringen, O.Moe, M.Bakunowicz-Lazarczyk, A.Reich-d’Almeida, F.Marques Neves, C.Reich d’Almeida, I.Oliveira, M.Vladutiu, C.Stankovic, B.Djokić, V.Gerinec, A.Stirn Kranjc, B.Gomez-de-Liano Sanchez, R.Rajmil, L.Prats, B.Nilsson, J.Flodin, Sara, 1974; Landau, K.Sturm, V.Zuber, C.Glauser, V.Atilla, H.Horwood, A. M.Williams, C.Shea, S.Griffiths, H.Carlton, J.Qirjazi, BirkenaGugatschka, MarkusStappaerts, LucVos, BénédicteMilkov, MarioVelepic, MarkoThodi, ChryssoulaSyka, JosefOvesen, Therese
Journal of Medical Screening. 22(2):55-64
Academic Journal
European Journal of Drug Metabolism and Pharmacokinetics. September 2005 30(3):195-201
Academic Journal
Berry, SnehaGiraldo, NicolasNguyen, PeterGreen, BenjaminXu, HaiyingOgurtsova, AleksandraSoni, AbhaSuccaria, FarahWang, DaphneRoberts, CharlesStein, JulieEngle, ElizabethPardoll, DrewAnders, RobertCottrell, TriciaTaube, Janis M.Tran, BenVoskoboynik, MarkKuo, JamesBang, Yung-LueChung, Hyun-CheoAhn, Myung-JuKim, Sang-WePerera, AyeshFreeman, DanielAchour, IkbelFaggioni, RaffaellaXiao, FengFerte, CharlesLemech, CharlotteMeric-Bernstam, FundaWerner, TheresaHodi, StephenMessersmith, WellsLewis, NancyTalluto, CraigDostalek, MirekTao, AiyangMcWhirter, SarahTrujillo, DamianLuke, JasonXu, ChunxiaoBoMarelliQi, JinQin, GuozhongYu, HuakuiJenkins, MollyLo, Kin-MingHalle, Joern-PeterLan, YanTaylor, MatthewVogelzang, NicholasCohn, AllenStepan, DanielShumaker, RobertDutcus, CorinaGuo, MatthewSchmidt, EmmettRasco, DrewBrose, MarciaVogelzang, NicholasDi Simone, ChristopherJain, SharadRichards, DonaldEncarnacion, CarlosRasco, DrewShumaker, RobertDutcus, CorinaStepan, DanielGuo, MatthewSchmidt, EmmettTaylor, MatthewVogelzang, NicholasEncarnacion, CarlosCohn, AllenDi Simone, ChristopherRasco, DrewRichards, DonaldTaylor, MatthewDutcus, CorinaStepan, DanielShumaker, RobertGuo, MatthewSchmidt, EmmettMier, JamesAn, JeongshinYang, Yeun-yeoulLee, Won-HeeYang, JinhoKim, Jong-kyuKim, Hyun GooPaek, Se HyunLee, Jun WooWoo, JoohyunKim, Jong BinKwon, HyungjuLim, WoosungPaik, Nam SunKim, Yoon-KeunMoon, Byung-InJanku, FilipTan, DavidMartin-Liberal, JuanTakahashi, ShunjiGeva, RavitGucalp, AycaChen, XueyingSubramanian, KulandayanMataraza, JenniferWheler, JenniferBedard, Philippe
Journal for ImmunoTherapy of Cancer. 7(1)
Academic Journal
Grauel AL; Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Nguyen B; Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Ruddy D; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Laszewski T; Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Schwartz S; Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Chang J; Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Chen J; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Piquet M; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Pelletier M; Oncology Translational Research, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Yan Z; Oncology Translational Research, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Kirkpatrick ND; Biotherapeutic and Analytical Technologies, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Wu J; Oncology Data Science, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; deWeck A; Oncology Data Science, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Riester M; Oncology Data Science, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Hims M; Oncology Translational Research, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Geyer FC; Oncology Translational Research, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Wagner J; Oncology Data Science, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; MacIsaac K; Oncology Data Science, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Deeds J; Oncology Translational Research, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Diwanji R; Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Jayaraman P; Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Yu Y; Oncology Translational Research, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Simmons Q; Oncology Data Science, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Weng S; Oncology Translational Research, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Raza A; Oncology Translational Research, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Minie B; Oncology Data Science, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Dostalek M; PKS Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Chikkegowda P; Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Ruda V; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Iartchouk O; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Chen N; Oncology Data Science, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Thierry R; Biotherapeutic and Analytical Technologies, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Zhou J; Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Pruteanu-Malinici I; Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Fabre C; Translational Clinical Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Engelman JA; Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Dranoff G; Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA.; Cremasco V; Immuno-Oncology, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA, 02139, USA. viviana.cremasco@novartis.com.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Dostalek, M
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어